Perceptions of clinical care and research among African-American patients with lymphoma

References

• Teras LR, DeSantis CE, Cerhan JR, et al. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443–459.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107(1):265–276.
   PubMed Web of Science ®Google Scholar
• Ayers AA, Lyu L, Dance K, et al. Characterizing lymphoma incidence and disparities for a cancer center catchment region. Clin Lymphoma Myeloma Leuk. 2019;19(11):699.e5–708.e5.
   Web of Science ®Google Scholar
• Becnel M, Flowers CR, Nastoupil LJ. Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation. Ann Lymphoma. 2017;1:1–1.
   Google Scholar
• Flowers CR, Fedewa SA, Chen AY, et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012;21(9):1520–1530.
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Sinha R, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011;11(6):498–506.
   PubMed Web of Science ®Google Scholar
• Abouyabis AN, Shenoy PJ, Lechowicz MJ, et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008;49(11):2099–2107.
   PubMed Web of Science ®Google Scholar
• Nabhan C, Byrtek M, Taylor MD, et al. Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Cancer. 2012;118(19):4842–4850.
   PubMed Web of Science ®Google Scholar
• Nabhan C, Zhou X, Day BM, et al. Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States. Am J Hematol. 2016;91(8):770–775.
   PubMed Web of Science ®Google Scholar
• Goldstein JS, Nastoupil LJ, Han X, et al. Disparities in survival by insurance status in follicular lymphoma. Blood. 2018;132(11):1159–1166.
   PubMed Web of Science ®Google Scholar
• Goldstein JS, Switchenko JM, Behera M, et al. Insurance status impacts overall survival in Burkitt lymphoma. Leuk Lymphoma. 2019;60(13):3225–3234.
   PubMed Web of Science ®Google Scholar
• Han X, Jemal A, Flowers CR, et al. Insurance status is related to diffuse large B-cell lymphoma survival. Cancer. 2014;120(8):1220–1227.
   PubMed Web of Science ®Google Scholar
• Keegan TH, DeRouen MC, Parsons HM, et al. Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: a population-based study. Cancer Epidemiol Biomarkers Prev. 2016;25(2):264–273.
   PubMed Web of Science ®Google Scholar
• Keegan THM, Li Q, Steele A, et al. Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors. Cancer Causes Control. 2018;29(6):551–561.
   PubMed Web of Science ®Google Scholar
• Shah NN, Xi Y, Liu Y, et al. Racial and socioeconomic disparities in mantle cell lymphoma. Clin Lymphoma Myeloma Leuk. 2019;19(6):e312–e320.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Shenoy PJ, Borate U, et al. Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma. 2013;54(2):268–276.
   PubMed Web of Science ®Google Scholar
• Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2011;117(11):2530–2540.
   PubMed Web of Science ®Google Scholar
• Flowers CR, Nastoupil LJ. Socioeconomic disparities in lymphoma. Blood. 2014;123(23):3530–3531.
   PubMed Web of Science ®Google Scholar
• Williams S, Ayers AA, Hildebrandt MAT, et al. Strategies for overcoming disparities for patients with hematologic malignancies and for improving enrollment on clinical trials oncology (williston park). Oncology (Williston Park). 2020;34(6):216–223.
   PubMed Web of Science ®Google Scholar
• Corbie-Smith G. Tuskegee as a metaphor. Science. 1999;285:47.
   PubMedGoogle Scholar
• Corbie-Smith G, Thomas SB, Williams MV, et al. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14(9):537–546.
   PubMed Web of Science ®Google Scholar
• Davis TC, Arnold CL, Mills G, et al. A qualitative study exploring barriers and facilitators of enrolling underrepresented populations in clinical trials and biobanking. Front Cell Dev Biol. 2019;7:74.
   PubMed Web of Science ®Google Scholar
• Vuong I, Wright J, Nolan MB, et al. Overcoming barriers: evidence-based strategies to increase enrollment of underrepresented populations in cancer therapeutic clinical trials-a narrative review. J Cancer Educ. 2019;35(5):841–849.
   Web of Science ®Google Scholar
• Scharff DP, Mathews KJ, Jackson P, et al. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010;21:879–897.
   PubMed Web of Science ®Google Scholar
• Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88:630–634.
   PubMed Web of Science ®Google Scholar
• Haynes TF, Cheney AM, Sullivan JG, et al. Addressing mental health needs: perspectives of African Americans living in the rural south. Psychiatr Serv. 2017;68(6):573–578.
   PubMed Web of Science ®Google Scholar
• Hughes TB, Varma VR, Pettigrew C, et al. African Americans and clinical research: evidence concerning barriers and facilitators to participation and recruitment recommendations. Gerontologist. 2017;57(2):348–358.
   PubMed Web of Science ®Google Scholar
• Polite BN, Adams-Campbell LL, Brawley OW, et al. Charting the future of cancer health disparities research: a position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol. 2017;35(26):3075–3082.
   PubMed Web of Science ®Google Scholar
• Vickers SM, Fouad MN. An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual. Cancer. 2014;120 Suppl 7 (Suppl 7):1087–1090.
   PubMedGoogle Scholar
• Durant RW, Wenzel JA, Scarinci IC, et al. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer. 2014;120 Suppl 7 (Suppl 7):1097–1105.
   PubMedGoogle Scholar
• Chen MS, Jr., Lara PN, Dang JH, et al. Twenty years post-NIH revitalization act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014;120(Suppl 7):1091–1096.
   PubMedGoogle Scholar
• Fusch P, Ness L. Are we there yet? Data saturation in qualitative research. Qual Rep. 2015;20:1408–1416.
   Web of Science ®Google Scholar
• Chen L, Payne JB, Dance KV, et al. Priorities for rural lymphoma survivors: a qualitative study. Clin Lymphoma Myeloma Leuk. 2020;20(1):47.e3–52.e43.
   Web of Science ®Google Scholar
• Payne JB, Dance KV, Farone M, et al. Patient and caregiver perceptions of lymphoma care and research opportunities: a qualitative study. Cancer. 2019;125(22):4096–4104.
   PubMed Web of Science ®Google Scholar
• Corbin JM, Strauss AL. Basics of qualitative research: techniques and procedures for developing grounded theory. Vol. xviii. Los Angeles: SAGE; 2015. p. 431.
   Google Scholar
• Wells AA, Zebrack B. Psychosocial barriers contributing to the under-representation of racial/ethnic minorities in cancer clinical trials. Soc Work Health Care. 2008;46(2):1–14.
   PubMed Web of Science ®Google Scholar
• Penner LA, Dovidio JF, Hagiwara N, et al. An analysis of race-related attitudes and beliefs in black cancer patients: implications for health care disparities. J Health Care Poor Underserved. 2016;27(3):1503–1520.
   PubMed Web of Science ®Google Scholar
• Rivers D, August EM, Sehovic I, et al. A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials. 2013;35(2):13–32.
   PubMed Web of Science ®Google Scholar
• Peek ME, Gorawara-Bhat R, Quinn MT, et al. Patient trust in physicians and shared decision-making among African-Americans with diabetes. Health Commun. 2013;28(6):616–623.
   PubMed Web of Science ®Google Scholar
• Martinez MR, Pasha A. Prioritizing mental health research in cancer patients and survivors. AMA J Ethics. 2017;19:486–492.
   PubMedGoogle Scholar
• Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol. 2002;20(23):4581–4590.
   PubMed Web of Science ®Google Scholar
• Beraldi A, Kukk E, Nest A, et al. Use of cancer-specific mental health resources-is there an urban-rural divide? Support Care Cancer. 2015;23(5):1285–1294.
   PubMed Web of Science ®Google Scholar
• Paterick TE, Patel N, Tajik AJ, et al. Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent). 2017;30(1):112–113.
   PubMedGoogle Scholar
• Brown M, Moyer A. Predictors of awareness of clinical trials and feelings about the use of medical information for research in a nationally representative US sample. Ethn Health. 2010;15(3):223–236.
   PubMed Web of Science ®Google Scholar
• Regnante JM, Richie NA, Fashoyin-Aje L, et al. US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract. 2019;15(4):e289–e299.
   PubMed Web of Science ®Google Scholar
• Battaglia TA, Darnell JS, Ko N, et al. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat. 2016;158(3):523–534.
   PubMed Web of Science ®Google Scholar
• Freund KM. Implementation of evidence-based patient navigation programs. Acta Oncol. 2017;56(2):123–127.
   PubMed Web of Science ®Google Scholar
• Natale-Pereira A, Enard KR, Nevarez L, et al. The role of patient navigators in eliminating health disparities. Cancer. 2011;117(15 Suppl):3543–3552.
   PubMed Web of Science ®Google Scholar
• Fouad MN, Acemgil A, Bae S, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract. 2016;12(6):556–563.
   PubMed Web of Science ®Google Scholar